Jennifer Buell

CIK 1711184 · See Remarks · last filed 2026-04-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$741.0K

Companies

3

Total Filings

35

Lifetime Open-Market Net

-$12.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGEN See Remarks 19,738 $6.60 $130.3K -$12.2K 23 2026-04-28
INKT Chief Executive Officer 57,942 $10.54 $610.7K $0 10 2026-01-14
Protagenic Therapeutics, Inc.\new (PTIXW) Delisted Director $0.01 $0 1 2024-03-29

Recent Filings · Page 3 of 4

35 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-09-29 INKT Exer (M) +695,750 $0 EDGAR
2023-01-11 INKT Grant (A) +171,990 $399.0K EDGAR
2022-01-25 INKT Grant (A) $0 EDGAR
2021-07-02 AGEN Grant (A) +10,597 $58.2K EDGAR
2021-04-05 AGEN Grant (A) +80,838 $232.0K EDGAR
2020-12-21 AGEN Grant (A) $0 EDGAR
2020-07-21 Grant (A) $0
2020-06-17 AGEN Grant (A) $0 EDGAR
2019-12-27 AGEN Grant (A) $0 EDGAR
2019-07-25 AGEN Grant (A) $0 EDGAR
Showing 2130 of 35
Page 3 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.